Pacini, Aurélien
Shotar, Eimad
Granger, Benjamin
Maizeroi-Eugène, Franck
Delaitre, Mariette
Talbi, Atika
Boch, Anne-Laure
Valéry, Charles-Ambroise
Premat, Kévin
Drir, Mehdi
Lenck, Stéphanie
Mounayer, Charbel
Sourour, Nader-Antoine
Clarençon, Frédéric
Article History
Received: 30 November 2022
Accepted: 22 May 2023
First Online: 28 June 2023
Conflict of interest
: N.-A. Sourour is consultant for Medtronic, Balt Extrusion, Microvention, Stock/Stock Options: Medina. F. Clarençon reports conflict of interest with Medtronic, Guerbet, Balt Extrusion, Penumbra (payment for readings; non-related to the study), Codman Neurovascular and Microvention (core lab; non-related to the study). A. Pacini, E. Shotar, B. Granger, F. Maizeroi-Eugène, M. Delaitre, A. Talbi, A.-L. Boch, C.-A. Valéry, K. Premat, M. Drir, S. Lenck and C. Mounayer report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. The manuscript is not supported by industry.